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The Integrated Medical Model (IMM) is a probabilistic model that uses simulation to 
predict human spaceflight mission medical risk. Given a specific mission and crew scenario, 
medical events are simulated using Monte Carlo methodology to provide estimates of resource 
utilization, probability of evacuation, probability of loss of crew, and the amount of mission 
time lost due to illness. Mission and crew scenarios are defined by mission length, 
extravehicular activity (EVA) schedule, and crew characteristics including: sex, coronary 
artery calcium score, contacts, dental crowns, history of abdominal surgery, and EVA 
eligibility. 
The Integrated Medical Evidence Database (iMED) houses the model inputs for 100 
medical conditions using in-flight, analog, and terrestrial medical data. Inputs include 
incidence, event durations, resource utilization, and crew functional impairment. Severity of 
conditions is addressed by defining statistical distributions on the dichotomized best and 
worst-case scenarios for each condition. The outcome distributions for conditions are bounded 
by the treatment extremes of the fully treated scenario – in which all required resources are 
available – and the untreated scenario – in which no required resources are available. Upon 
occurrence of a simulated medical event, treatment availability is assessed, and outcomes are 
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generated depending on the status of the affected crewmember at the time of onset, including 
any pre-existing functional impairments or ongoing treatment of concurrent conditions.  
The main IMM outcomes, including probability of evacuation and loss of crew life, time 
lost due to medical events, and resource utilization, are useful in informing mission planning 
decisions. To date, the IMM has been used to assess mission-specific risks with and without 
certain crewmember characteristics, to determine the impact of eliminating certain resources 
from the mission medical kit, and to design medical kits that maximally benefit crew health 
while meeting mass and volume constraints.  
I. Introduction 
ERIOUS medical consequences associated with the extreme space environment represent a potentially significant 
limiting factor for long-duration human spaceflight. Given the relative dearth of opportunities to study the 
physiologic effects of the space environment and the difficulties in mimicking such conditions through analog 
environments, computational models serve to augment space medicine research, assess risk, prioritize funding 
decisions, and ultimately aid in mitigating potential hazards to astronaut health. Many of these models produce 
simulations that answer targeted questions about human physiologic changes in response to spaceflight and the 
microgravity environment.1-8 To complement these efforts, a broad view of in-flight astronaut health and resource 
usage is useful to program, project, and mission planners in establishing meaningful mission parameters for crew 
health and safety. Assad et al. published a deterministic model of astronaut health and resource utilization for long-
duration spaceflight that provides an aggregate estimate of astronaut health and the mass of medical consumables used 
during the mission.9 The Integrated Medical Model (IMM) expands upon these capabilities by providing a measure of 
quality time lost during the mission due to medical events, the probability of evacuation, the probability of loss of 
crew life, and resource utilization. Granularity at the medical condition level and resource type level is also achieved 
and provides information about drivers of evacuation, loss of crew, and overall poor health.  
 As a quantitative, evidence-based decision support tool that integrates organizational knowledge, published 
literature, and in-flight medical event data, the IMM provides comparative estimates of in-flight medical risks and 
resource utilization between different mission profiles, crew profiles, and medical kits. This probabilistic simulation 
uses Monte Carlo methodology with input from medical condition incidence data, medical condition outcome data, 
and treatment data on 100 medical conditions that have either occurred in flight or are of considerable concern to 
human spaceflight. Using these medical inputs,  combined with crew and mission characteristics, the IMM generates 
a large number of simulated missions to predict the amount of time lost during the mission due to medical events, the 
probability of evacuation, the probability of a loss of crew life, and an estimate of resources required. As certain 
medical conditions have higher likelihoods if an individual has an associated risk factor (e.g., use of contacts is 
correlated with a  greater risk of corneal ulcer), the IMM takes as input a crew profile defining several risk factors, 
including sex, presence of contacts, presence of coronary artery calcium, presence of crowns, and history of abdominal 
surgery. Further, medical conditions associated with space adaptation (SA) are modeled to occur only once in flight. 
 The IMM goes beyond more traditional risk management tools in that it not only models risk, it also models risk 
mitigations in the form of medical condition treatment, and subsequent clinical outcomes based on medical resource 
mitigations available. The IMM also accounts for events unique to the spaceflight environment, such as solar particle 
events (SPE), which expose the crew to radiation, and extravehicular activities (EVAs), or ‘spacewalks’, that may 
lead to associated conditions and adverse medical outcomes. The model exhibits sufficient flexibility to allow for 
additional mission event types should data be made available. Currently, the input data is baselined to the International 
Space Station; however, the IMM is designed to be extensible,  to support research, and to support capability 
development in order to enable long-term exploration class missions.  
 
II. Methods 
The IMM is implemented in MATLAB and draws model inputs from user-defined scripts and an SQL database.10 
In concept, the IMM architecture follows the practices of probabilistic risk assessment (PRA).11 However, the 
implementation of the IMM diverges from strict PRA implementation to accommodate the broad assumptions required 
to implement medical treatment and outcome simulations. These enhancements maintain appropriate statistical 
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practices and result in a robust and extensible tool. Figures 1 and 2 provide overviews of model inputs and simulation 
flow, respectively. 
 
 
 
A. Model Inputs 
A SQL database called the integrated Medical Evidence Database (iMED) houses the medical-condition-model 
inputs. Within the database, clinical subject matter experts (SMEs) populate and maintain data on 100 medical 
conditions that have either occurred in flight or are of considerable concern or interest to human spaceflight. The 
following section outlines the data housed in the iMED and used by the model.  
 
Figure 1. Summary of IMM inputs and outputs. 
 
 
1. User-defined 
Model users must define the mission, number of crew, and certain crewmember characteristics including sex, 
presence of dental crowns, presence of contact lenses, presence of coronary artery calcium (CAC), and history of 
abdominal surgery. An EVA schedule must also be defined for each crewmember. These crew characteristics indicate 
the appropriate incidence data for applicable medical conditions associated with crew-health-risk factors. 
 
2. Incidence Rates 
 In-flight data inform the medical condition incidence data for the medical conditions simulated in the IMM 
wherever possible. The NASA Lifetime Surveillance of Astronaut Health (LSAH) and information from published 
literature provides the IMM with in-flight data.12-14 The current version of the model uses in-flight data from shuttle 
missions STS 1-114, except STS-51-L (Challenger) and STS-107 (Columbia), International Space Station expeditions 
1-13, Apollo, Skylab, and Shuttle/Mir. Data from some later flights inform medical condition inputs related to visual 
impairment and intracranial pressure (VIIP).  
Where observational data are insufficient to adequately define the in-flight medical risk, the IMM uses terrestrial 
analog and general population data, Bayesian updates to pre- and postflight astronaut data from terrestrial data15, 
analog condition terrestrial data, and external probabilistic modules to model and estimate medical-event 
likelihoods. Acquisition of terrestrial incidence is through analog and general population published literature. For 
some medical conditions, such as the occurrence of in-flight renal stones, Bayesian updates can be made to 
terrestrial data. External models are used to estimate incidence of very rare, but high impact, events, such as the a 
bone-fracture-risk model.16 The current list of the IMM medical conditions, along with the incidence data source 
type (i.e., in-flight data, terrestrial data, Bayesian updates to terrestrial data, or external model data), and the 
distributions sampled for each incidence rate may be found in the Appendix. Medical conditions associated with 
causative mission events and risk factors affecting medical condition likelihoods, are also indicated. 
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3. Scenario 
The severity of a medical condition occurrence is modeled as a best- or worst-case event scenario with medical 
event outcomes defined separately for each scenario. Outcomes associated with these two scenarios represent the best 
and worst possible outcomes for the affected crewmember given defined resource, treatment, and environmental 
constraints. The probability of a best or worst-case scenario is specified in the iMED as being uniformly distributed 
over a range defined by clinical SMEs and informed by the literature for each of the medical conditions.  
 
4. Treatment 
The IMM models mitigations to the medical risks in the form of treatments. Resource types and quantities used to 
model medical risk mitigation in the IMM are derived from the International Space Station (ISS) Health Maintenance 
System. A treatment is defined for each medical condition/scenario combination and consists of required quantities of 
medical resources, the per day dosage, and a resource category, if applicable. The resource is assigned to a category 
so that in the event of an insufficient quantity of a primary resource, a suitable alternate may be considered from the 
same category during simulation. The iMED contains an alternative resource table that lists equivalent dosages for 
resources within the same category. Treatments are defined by clinical SMEs to reflect acceptable medical standards 
of care. 
 
5. Outcomes 
 Medical event outcomes are defined in the iMED for each medical event/scenario combination for the situation 
where sufficient medical resources are available to treat the medical condition and the situation where insufficient 
resources are available. These outcomes include functional impairments, durations, the probability that an evacuation 
should be considered (pEVAC), and the probability of loss of crew life (meaning one or more crew) (pLOCL). 
Functional impairments and durations, and pEVAC and pLOCL are generated using beta-pert distributions. Functional 
impairments (FI) and durations (DT) are defined for each of three clinical phases: diagnosis and initial treatment 
(Clinical Phase 1), ongoing treatment and convalescence (Clinical Phase 2), and permanent impairment for the 
remainder of the mission (Clinical Phase 3). FI and DT are specified as ranges (min and max) assuming a Beta-Pert 
distribution with the midpoint serving as the most likely value. FI, DT, and end state outcome (pLOCL and pEVAC) 
specifications are ascertained from a combination of impairment guidelines, best evidence from ground-based analog 
populations, and clinical SME experience with the medical condition.17 It should be noted that evacuation and loss of 
crew life endstate data is not drawn from in-flight data, as these 
events are rare. As end-state outcomes are largely impacted by 
medical resource limitations, their specification relies heavily on 
clinical expertise within the NASA community.  
B. Simulation 
 
6. Medical Condition Occurrences  
SA conditions are simulated to occur at most once during the 
mission and, with the exception of conditions associated with 
VIIP, occur within the first 5 days. The incidence of a SA 
condition is defined in the iMED as an incidence proportion (IP) 
or events per person task. The IP is either fixed or generated from 
a Beta distribution, and the occurrence of the event is drawn from 
a Bernoulli distribution defined by the IP. If the SA medical 
condition occurs, the time-of-occurrence is then generated from 
a Beta-Pert distribution specified in the iMED. 
 For each scheduled EVA for a crewmember, an EVA-
associated medical event occurrence is drawn from a Bernoulli 
distribution defined by the medical condition IP, which is either 
fixed or generated from a Beta distribution. If the event occurs, the time-of-occurrence is the start time of the scheduled 
EVA.  
 The only condition currently in the model that is associated with 
SPEs is acute radiation syndrome (ARS). An SPE incidence is generated from a gamma distribution defined in the 
iMED, and SPEs are simulated as a Poisson process with time between events generated via an exponential distribution 
with lambda equal to the incidence rate (IR). The SPE schedule is generated in this way at the beginning of every 
Figure 2. Overview of IMM simulation. 
 
 International Conference on Environmental Systems 
 
 
5 
mission. If an SPE occurs, all crewmembers are at risk for ARS. ARS occurrences are predicted from a Bernoulli 
distribution defined by a fixed incidence proportion.  
 For general conditions (non-EVA, non-SPE, and non-SA), medical event occurrences are simulated as a Poisson 
process with time between events generated via an exponential distribution with lambda equal to the incidence rate.  
For all medical condition occurrences, the best-case or worst-case scenario type is generated from a Bernoulli 
distribution. 
 
7. Treatment 
Within the simulation, medical resources used to treat each 
medical event are taken out of the medical kit the order of 
medical event occurrence. While the resource types and 
quantities are specified model inputs, these treatments may be 
modified within the simulation to account for remaining 
mission time (for example, if the medical event occurs near the 
end of the mission), or to account for overlap with treatment 
of concurrent conditions within the same crewmember. If a 
required resource is unavailable or the quantity is insufficient 
and an alternative is specified in the iMED, the alternate will 
be used as the mitigation. Note that medical event outcomes 
are simulated from statistical distributions that are specified 
for the situation where all required resources are available 
(fully treated) and also when no required resources are 
available (untreated). To predict outcomes for a medical event 
where some but not all of the required essential resources are 
available to treat the medical event, a partial treatment scheme 
is employed that allows for a continuum between the fully-
treated and untreated situations. To address partial treatment 
outcomes between these two extremes, we use a resource availability factor (RAF), calculated as the proportion of 
required resources available, to generate statistical distributions that are shifted between the fully treated and 
completely untreated distributions (Figure 3).  
  
8. Outcomes 
Functional impairments and clinical phase durations, and probabilities of loss of crew and evacuation are generated 
from Beta-Pert distributions. Loss of crew and evacuation are simulated from Bernoulli distributions using the 
generated probabilities. Simulated outcomes for a given medical event may affect downstream events on the timeline. 
If a medical condition results in an evacuation or loss of crew life, no further medical events may occur for the affected 
crewmember. Furthermore, a crewmember in Clinical Phases 1 and 2 of a medical event may not experience a second 
concurrent occurrence of the identical medical event during that time.  
 
9. Outputs 
Primary outcomes describing the impact of medical events on the mission are measured by the Crew Health Index 
(CHI), probability of evacuation (pEVAC), probability of loss of crew life (pLOCL), and total medical events (TME). 
The CHI is a function of quality-adjusted life years lost due to medical events. Given n overlapping functional 
impairments <f1,f2, f3,…,fn> at a point in time within a crewmember due to medical events, the overall functional 
impairment ftotal can be calculated using function: ftotal = 1-(1-f1)×(1-f2) × (1-f3) ×…× (1-fn). The quality time lost is 
calculated as the product of ftotal and the duration of the time interval over which the functional impairment is applied. 
Total quality time lost (QTL) over a mission is calculated as the sum of products of the functional impairments and 
durations. The CHI is an estimate of total jcrew health and is calculated in the following way: CHI = 100%×(1-
QTLtotal/(L×c)) where c is the number of crew, L is the mission length in hours, and QTLtotal is the total amount of 
quality time lost for all crewmembers on a mission. The contributions of individual medical conditions to each primary 
output, as well as descriptive statistics on the individual resources used are also available. 
III. Results 
Example results from 100k trials for an ISS 6-month Design Reference Mission (DRM) with a 4-male, 2-female 
crew are provided here. Crew risk factors include: 1 crewmember with a CAC score greater than zero, 3 crewmembers 
Figure 3. Sample statistical distributions for functional 
impairment (FI) for varying RAF values ranging from 100% 
(all required resources available) to 0% (no required 
resources available). 
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with contacts, 2 crewmembers with crowns, 1 crewmember with a history of abdominal surgery, and 2 crewmembers 
who perform 6 EVAs each. Three risk mitigation scenarios are modeled: one in which no medical resources are 
available, one in which the ISS Health Maintenance System is available (with no resupply), and one in which unlimited 
quantities of consumables in the ISS Health Maintenance System are available. A summary of these outputs can be 
found in Table 1, and the distributions that some of these outputs assume can be seen in Figures 4-5. The outputs 
provided here are for the crewmembers as an aggregate. As is expected, the worst CHI, pEVAC and pLOCL outcomes 
occur in the untreated scenario, with outcomes improving as more resources become available. Notably, total medical 
events (TME) are reduced in the scenario where no medical resources are available. This is reflective of the increased 
precedence of early termination of crewmembers’ missions due to death or evacuation. For comparison, CHI data 
from an exploration-class Mars 2.5-year DRM is provided in Figure 6 with available medical resources derived from 
the ISS Health Maintenance System and with an identical crew profile to the ISS DRM with the exception that 2 
crewmembers perform 2 EVAs per week each. Figure 7 provides a comparison of CHI on the ISS 6-month and Mars 
2.5-year DRMS with limited quantities of ISS Health Maintenance System resources available.  
 
Table 1. ISS 6 month, 6 crew mission. 
 
 
 
 
Figure 4. Total medical events for three medical risk mitigation scenarios for an ISS 6-month, 6-crew mission. 
Lower 
Bound
Upper 
Bound
Lower 
Bound
Upper 
Bound
Lower 
Bound
Upper 
Bound
TME 98.3 73 122 106 87 126 106 87 126
CHI 59.2 43.36 71.25 94.93 84.32 98.46 94.98 84.44 98.47
pEVAC 66.9 66.57 67.14 5.57 5.43 5.72 4.93 4.8 5.07
pLOCL 2.89 2.78 2.99 0.44 0.4 0.49 0.45 0.41 0.49
No Medical Resources
ISS Health 
Maintenance System
Unlimited Medical 
Resources
Mean
95% Confidence 
Interval
Mean
95% Confidence 
Interval
Mean
95% Confidence 
Interval
 International Conference on Environmental Systems 
 
 
7 
 
Figure 5. Crew health index over 100,000 trials for an ISS 6-month, 6-crew mission. 
 
 
 
Figure 6. Crew health index over 100,000 trials for a Mars 2.5-year, 6-crew mission. 
 
 
Figure 7. Crew Health Index comparison with limited quantities of resources from the ISS Health Maintenance System available on ISS 
6-month and Mars 2.5-year missions. 
IV. Conclusions 
 Effective risk management is an integral aspect of human spaceflight and is critical to program and project success. 
The IMM serves as a quantitative, objective tool for risk managers and mission planners by providing aggregate 
risks that can be compared across mission profiles as well as more granular information such as medical conditions, 
crew characteristics, and mitigations most influential to those risks. For example, the IMM has been used to 
determine the impact of certain resources being unavailable, the impact of crewmember medical attributes, and 
which consumable resources are most sought on a long-duration mission. Information from the IMM has also been 
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used for a medical kit optimization routine that generates medical kits to meet mass and volume constraints while 
maximizing CHI or minimizing pLOCL and pEVAC for specified mission and crew profile constraints.18 
 The IMM was initially developed for ISS planning, and model inputs were baselined to the ISS. To make the 
model more meaningful for exploration-class mission, some model outputs could be reconsidered. For example, on 
exploration missions, evacuation is not possible in the same sense as was intended when the parameter was initially 
developed. A loss-of-mission output metric might be more meaningful in the context of exploration missions and 
this development is currently underway. Further, the complexities of multiple co-morbidities and the effects of a 
crewmember with a communicable medical condition on the probability that other crewmembers contract the same 
illness are not modeled. Future work might also include modeling ISS countermeasures beyond medical resources, 
such as the advanced resistive exercise device (ARED) and treadmill, modeling the failure of medical risk 
mitigations, modeling radiation risks beyond those associated with SPEs, and modeling vehicle environmental 
systems with medical condition correlates. 
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Appendix 
Medical Condition 
Incidence Data 
Source 
Incidence 
Distribution 
Risk factors 
Abdominal Injury Terrestrial Gamma  
Abdominal Wall Hernia Terrestrial Gamma  
Abnormal Uterine Bleeding Terrestrial Fixed Sex 
Acute Arthritis Terrestrial Fixed Sex 
Acute Cholecystitis/Biliary Colic 
Astronaut pre- and 
postflight data, 
Terrestrial data 
Lognormal Sex 
Acute Compartment Syndrome Terrestrial Fixed Sex 
Acute Diverticulitis Terrestrial Fixed  
Acute Glaucoma Terrestrial Fixed Sex 
Acute Pancreatitis Terrestrial Fixed  
Acute Prostatitis Terrestrial Fixed Sex 
Acute Radiation Syndrome Terrestrial Fixed SPE 
Acute Sinusitis In-flight Gamma  
Allergic Reaction (mild to moderate) In-flight Gamma  
Altitude Sickness Terrestrial Lognormal  
Anaphylaxis Terrestrial Fixed  
Angina/Myocardial Infarction Terrestrial Fixed Sex 
Ankle Sprain/Strain In-flight Gamma  
Anxiety Terrestrial Fixed Sex 
Appendicitis 
Astronaut pre- and 
postflight data, 
Terrestrial data 
Lognormal  
Atrial Fibrillation/ Atrial Flutter 
Astronaut pre- and 
postflight data, 
Terrestrial data 
Lognormal Sex 
Back Injury In-flight Gamma  
Back Pain (Space Adaptation) In-flight Beta  
Barotrauma (ear/sinus block) In-flight Gamma  
Behavioral Emergency Terrestrial Fixed  
Burns secondary to Fire External model Fixed  
Cardiogenic Shock secondary to Myocardial Infarction Terrestrial Fixed Sex 
Chest Injury Terrestrial Gamma  
Choking/Obstructed Airway In-flight Gamma  
Constipation (space adaptation) In-flight Beta  
Decompression Sickness Secondary to Extravehicular 
Activity 
Terrestrial Beta EVA 
Dental : Exposed Pulp Terrestrial Fixed  
Dental Caries 
Astronaut pre- and 
postflight data, 
Terrestrial data 
Lognormal  
Dental: Abscess 
Astronaut pre- and 
postflight data, 
Terrestrial data 
Lognormal  
Dental: Avulsion (Tooth Loss) Terrestrial Fixed  
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Medical Condition 
Incidence Data 
Source 
Incidence 
Distribution 
Risk factors 
Dental: Crown Loss Terrestrial Fixed Crowns 
Dental: Filling Loss Terrestrial Fixed  
Depression Terrestrial Fixed Sex 
Diarrhea In-flight Gamma  
Elbow Dislocation Terrestrial Fixed  
Elbow Sprain/Strain In-flight Gamma  
Eye Abrasion (foreign body) In-flight Gamma  
Eye Chemical Burn In-flight Gamma  
Eye Corneal Ulcer Terrestrial Fixed Contacts 
Eye Infection In-flight Gamma  
Eye Penetration (foreign body) Terrestrial Fixed  
Finger Dislocation In-flight Gamma  
Fingernail Delamination In-flight Beta EVA 
Gastroenteritis In-flight Gamma  
Head Injury Terrestrial Gamma  
Headache (CO2 induced) In-flight Gamma  
Headache (Late) In-flight Gamma  
Headache (space adaptation) In-flight Beta  
Hearing Loss In-flight Gamma  
Hemorrhoids In-flight Gamma  
Herpes Zoster Reactivation (shingles) In-flight Gamma  
Hip Sprain/Strain In-flight Gamma  
Hip/Proximal Femur Fracture External model Lognormal Sex 
Hypertension Terrestrial Fixed  
Indigestion In-flight Gamma  
Influenza In-flight Gamma  
Insomnia (space adaptation) In-flight Beta  
Knee Sprain/Strain In-flight Gamma  
Late Insomnia In-flight Gamma  
Lower Extremity (LE) Stress Fracture Terrestrial Fixed Sex 
Lumbar Spine Fracture External model Lognormal Sex 
Medication Overdose/Adverse Reaction In-flight Gamma  
Mouth Ulcer In-flight Gamma  
Nasal Congestion (space adaptation) In-flight Beta  
Neck Injury In-flight Gamma  
Nephrolithiasis 
Astronaut pre- and 
postflight data, 
Terrestrial data 
Lognormal  
Neurogenic Shock Terrestrial Fixed  
Nose bleed (space adaptation) In-flight Beta  
Otitis Externa In-flight Gamma  
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Medical Condition 
Incidence Data 
Source 
Incidence 
Distribution 
Risk factors 
Otitis Media In-flight Gamma  
Paresthesias In-flight Beta EVA 
Pharyngitis In-flight Gamma  
Respiratory Infection In-flight Gamma  
Retinal Detachment Terrestrial Fixed Sex 
Seizures 
Astronaut pre- and 
postflight data, 
Terrestrial data 
Lognormal  
Sepsis Terrestrial Fixed  
Shoulder Dislocation Terrestrial Fixed  
Shoulder Sprain/Strain In-flight Gamma  
Skin Abrasion In-flight Gamma  
Skin Infection In-flight Gamma  
Skin Laceration In-flight Gamma  
Skin Rash In-flight Gamma  
Small Bowel Obstruction Terrestrial Fixed 
History of 
abdominal surgery 
Smoke Inhalation External model Fixed  
Space Motion Sickness (space adaptation) In-flight Beta  
Stroke (cerebrovascular accident) 
Astronaut pre- and 
postflight data, 
Terrestrial data 
Lognormal Sex 
Sudden Cardiac Arrest Terrestrial Fixed 
Coronary artery 
calcium 
Toxic Exposure: Ammonia External model Fixed  
Traumatic Hypovolemic Shock Terrestrial Fixed  
Urinary Incontinence (space adaptation) In-flight Beta Sex 
Urinary Retention (space adaptation) In-flight Beta Sex 
Urinary Tract Infection In-flight Gamma Sex 
Vaginal Yeast Infection Terrestrial Gamma Sex 
Visual Impairment and Intracranial Pressure (VIIP)(space 
adaptation) 
In-flight Beta  
Wrist Fracture External model Lognormal  
Wrist Sprain/Strain In-flight Gamma  
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